Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Antonio Codina Cazador is active.

Publication


Featured researches published by Antonio Codina Cazador.


Cirugia Espanola | 2011

Vólvulo de colon y recidiva del vólvulo: ¿qué debemos hacer?

Antonio Codina Cazador; Ramón Farres Coll; Francisco Olivet Pujol; Marcel Pujadas de Palol; Adam Martín Grillo; Nuria Gómez Romeu; David Julia Bergkvist

INTRODUCTION Colonic volvulus (CV) is an uncommon disease in our country, which may present clinically as an intestinal obstruction or occlusion. Its diagnosis and therapeutic management remains controversial. The objective of this article is to present our series, analyse the results and establish a therapeutic approach to decrease the recurrence of the volvulus. MATERIAL AND METHODS A retrospective, descriptive study of patients diagnosed with CV between January 1997 and December 2009. RESULTS The study included 54 patients, with a mean age of 74 years, who had a total of 89 CV episodes. There was associated disease in 70% of the cases, which included 44% with constipation and 53% with neurological diseases. The volvulus was located in the sigmoid in 87% of cases and in the right colon in 13%. The large majority (92%) of cases had intestinal obstruction. Endoscopic treatment was effective in 61% and urgent surgery was performed in 31% of the cases, and in 40% of the first episodes of CV. There was recurrence of volvulus in 62% of cases treated with surgery, and surgery was performed in 72% of these. In the whole series, surgery was performed in 35 cases (64%), with sigmoidectomy with primary anastomosis being the technique most employed. The overall mortality of the series was 7 cases (12%), with 16% being in cases of surgery due to recurrence. CONCLUSIONS The diagnostic technique and initial treatment of CV is endoscopic decompression. Early elective surgery prevents the high recurrence rate associated with higher mortality.


Cirugia Espanola | 2015

Resultados oncológicos según el tipo de resección en el tratamiento del cáncer de recto

Miguel Ángel Ciga Lozano; Antonio Codina Cazador; Héctor Ortiz Hurtado

OBJECTIVE This multicentre observational study aimed to compare outcomes of anterior resection (AR) and abdominal perineal resection (APR) in patients treated for rectal cancer. METHODS Between March 2006 and March 2009 a cohort of 1,598 patients diagnosed with low and mid rectal cancer were operated on in the first 38 hospitals included in the Spanish Rectal Cancer Project. In 1,343 patients the procedure was considered curative. Clinical and outcome results were analysed in relation to the type of surgery performed. All patients were included in the analysis of clinical results. The analysis of outcomes was performed only on patients treated by a curative procedure. RESULTS Of the 1,598 patients, 1,139 (71.3%) underwent an AR and 459 (28.7%) an APR. In 1,343 patients the procedure was performed with curative intent; from these 973 (72.4%) had an AR and 370 (27.6%) an APR. There were no differences between AR and APR in mortality (29 vs. 18 patients; P=.141). After a median follow up of 60.0 [49.0-60.0] months there were no differences in local recurrence (HR 1.68 [0.87-3.23]; P=.12), metastases (HR 1.31 [0.98-1.76]; P=.064). However, overall survival was worse after APR (HR 1.37 [1.00-1.86]; P=.048). CONCLUSION This study did not identify abdominoperineal excision as a determinant of local recurrence or metastases. However, patients treated by this operation have a decreased overall survival.OBJECTIVE This multicentre observational study aimed to compare outcomes of anterior resection (AR) and abdominal perineal resection (APR) in patients treated for rectal cancer. METHODS Between March 2006 and March 2009 a cohort of 1,598 patients diagnosed with low and mid rectal cancer were operated on in the first 38 hospitals included in the Spanish Rectal Cancer Project. In 1,343 patients the procedure was considered curative. Clinical and outcome results were analysed in relation to the type of surgery performed. All patients were included in the analysis of clinical results. The analysis of outcomes was performed only on patients treated by a curative procedure. RESULTS Of the 1,598 patients, 1,139 (71.3%) underwent an AR and 459 (28.7%) an APR. In 1,343 patients the procedure was performed with curative intent; from these 973 (72.4%) had an AR and 370 (27.6%) an APR. There were no differences between AR and APR in mortality (29 vs. 18 patients; P=.141). After a median follow up of 60.0 [49.0-60.0] months there were no differences in local recurrence (HR 1.68 [0.87-3.23]; P=.12), metastases (HR 1.31 [0.98-1.76]; P=.064). However, overall survival was worse after APR (HR 1.37 [1.00-1.86]; P=.048). CONCLUSION This study did not identify abdominoperineal excision as a determinant of local recurrence or metastases. However, patients treated by this operation have a decreased overall survival.


Cirugia Espanola | 2013

Resultados clínico-oncológicos de la respuesta patológica completa en el cáncer de recto después de tratamiento neoadyuvante

Antonio Codina Cazador; Ramón Farres Coll; Francesc Olivet Pujol; Adam Martín Grillo; Marcel Pujadas de Palol; Nuria Gómez Romeu; David Julia Bergkvist; Rosa Ortiz Duran; Ester Diez Gómez

INTRODUCTION Neoadjuvant chemo-radiotherapy is the treatment of choice for rectal cancer in order to reduce local recurrence. Patients with a pathological complete response (PCR) have a better prognosis. The aim of this study was to determine the influence of PCR on the oncological outcomes in our patients. METHODS All patients with stage ii/iii rectal cancer treated with neoadjuvant chemo-radiotherapy and radical resection between 2007 and 2011 were identified from a prospective database, and grouped based on whether they achieved PCR or not (non-PCR). Clinical, histological and oncological outcome data were compared. RESULTS A total of 162 patients were included (62% men), with a mean age of 65 years. In terms of pre-operative TNM staging, 82 patients (50%) were T2, 75 (46%) were T3, and 5 (3%) were T4. Forty-two patients (25%) were N1, and 87 (53%) were N2. Low anterior resection and abdominoperineal resection were performed in 125 (77%) and 25 (15%) patients. Forty-three patients (26.5%) had postoperative morbidity. PCR was achieved in 19 patients (11.7%). After a median follow-up of 26 months, there are no recurrences in the PCR group, and in the non-PCR group, local recurrence was 1.4% (P=.78), and distant metastasis was 8.4% (P=.21). Overall survival (P=.39) and survival free of diseases (P=.23) were better in the PCR group, but the differences were not significant. CONCLUSION Patients with pathological complete response have better oncological outcome.INTRODUCTION Neoadjuvant chemo-radiotherapy is the treatment of choice for rectal cancer in order to reduce local recurrence. Patients with a pathological complete response (PCR) have a better prognosis. The aim of this study was to determine the influence of PCR on the oncological outcomes in our patients. METHODS All patients with stage ii/iii rectal cancer treated with neoadjuvant chemo-radiotherapy and radical resection between 2007 and 2011 were identified from a prospective database, and grouped based on whether they achieved PCR or not (non-PCR). Clinical, histological and oncological outcome data were compared. RESULTS A total of 162 patients were included (62% men), with a mean age of 65 years. In terms of pre-operative TNM staging, 82 patients (50%) were T2, 75 (46%) were T3, and 5 (3%) were T4. Forty-two patients (25%) were N1, and 87 (53%) were N2. Low anterior resection and abdominoperineal resection were performed in 125 (77%) and 25 (15%) patients. Forty-three patients (26.5%) had postoperative morbidity. PCR was achieved in 19 patients (11.7%). After a median follow-up of 26 months, there are no recurrences in the PCR group, and in the non-PCR group, local recurrence was 1.4% (P=.78), and distant metastasis was 8.4% (P=.21). Overall survival (P=.39) and survival free of diseases (P=.23) were better in the PCR group, but the differences were not significant. CONCLUSION Patients with pathological complete response have better oncological outcome.


Cirugia Espanola | 2011

Colonic volvulus and recurrence of volvulus: What should we do?

Antonio Codina Cazador; Ramón Farres Coll; Francisco Olivet Pujol; Marcel Pujadas de Palol; Adam Martín Grillo; Nuria Gómez Romeu; David Julia Bergkvist

Abstract Introduction Colonic volvulus (CV) is an uncommon disease in our country, which may present clinically as an intestinal obstruction or occlusion. Its diagnosis and therapeutic management remains controversial. The objective of this article is to present our series, analyse the results and establish a therapeutic approach to decrease the recurrence of the volvulus. Material and methods A retrospective, descriptive study of patients diagnosed with CV between January 1997 and December 2009. Results There was recurrence of volvulus in 62% of cases treated with surgery, and surgery was performed in 72% of these. In the whole series, surgery was performed in 35 cases (64%), with sigmoidectomy with primary anastomosis being the technique most employed. The overall mortality of the series was 7 cases (12%), with 16% being in cases of surgery due to recurrence. The study included 54 patients, with a mean age of 74 years, who had a total of 89 CV episodes. There was associated disease in 70% of the cases, which included 44% with constipation and 53% with neurological diseases. The volvulus was located in the sigmoid in 87% of cases and in the right colon in 13%. The large majority (92%) of cases had intestinal obstruction. Endoscopic treatment was effective in 61% and urgent surgery was performed in 31% of the cases, and in 40% of the first episodes of CV. Conclusions The diagnostic technique and initial treatment of CV is endoscopic decompression. Early elective surgery prevents the high recurrence rate associated with higher mortality.


Cirugia Espanola | 2003

Estadificación preoperatoria del cáncer colorrectal

Antonio Codina Cazador; Ramón Farres Coll; Francisco Olivet Pujol

Resumen El tratamiento del cancer colorrectal exige una adecuada estadificacion preoperatoria con el objetivo de determinar la mejor opcion terapeutica. La estadificacion preoperatoria se basa en la evaluacion clinica, endoscopica y radiologica del tumor. En el presente capitulo se describen los metodos de estudio distinguiendo entre el cancer de colon y el cancer de recto, pues son entidades con un tratamiento diferenciado.


Cirugia Espanola | 2013

Clinical and Oncological Results of the Pathological Complete Response in Rectal Cancer After Neoadjuvant Treatment

Antonio Codina Cazador; Ramón Farres Coll; Francesc Olivet Pujol; Adam Martín Grillo; Marcel Pujadas de Palol; Nuria Gómez Romeu; David Julia Bergkvist; Rosa Ortiz Duran; Ester Diez Gómez


Cirugia Espanola | 2017

Resultados oncológicos del Proyecto docente del Cáncer de Recto en España 10 años después de su inicio

Antonio Codina Cazador; Sebastiano Biondo; Eloy Espin Basany; José M. Enríquez-Navascués; Eduardo García-Granero; José Vicente Roig Vila; Maria Buxó


Cirugia Espanola | 2017

Perforación rectal espontánea con evisceración transanal del intestino delgado. A propósito de un caso y revisión de la literatura

Helena Salvador Rosés; Laia Falgueras Verdaguer; Franco Marinello; Ramón Farres Coll; Antonio Codina Cazador


Cirugia Espanola | 2017

Spontaneous Perforation of the Rectum With Transanal Evisceration of the Small Bowel: A Case Report and Review of the Literature☆

Helena Salvador Rosés; Laia Falgueras Verdaguer; Franco Marinello; Ramón Farres Coll; Antonio Codina Cazador


Cirugia Espanola | 2017

Oncological Results of the Educational Rectal Cancer Project in Spain 10 Years After Its Implementation

Antonio Codina Cazador; Sebastiano Biondo; Eloy Espin Basany; José M. Enríquez-Navascués; Eduardo García-Granero; José Vicente Roig Vila; Maria Buxó

Collaboration


Dive into the Antonio Codina Cazador's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eloy Espin Basany

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Héctor Ortiz Hurtado

Universidad Pública de Navarra

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Franco Marinello

University of Alabama at Birmingham

View shared research outputs
Researchain Logo
Decentralizing Knowledge